Biogen

Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.

Facebook: 
LinkedIn: 
Twitter: 

Recent Video

Oct 13, 2022 9:00 AM ET
Jun 28, 2022 10:00 AM ET
Jun 22, 2022 10:00 AM ET

Recent Photos